Navigation Links
Midwest hotter for healthcare investments

Madison, Wis. - The Midwest is emerging as a hot market for bioscience investors who used to make nearly all of their investments on the coasts, according to a new report from BioEnterprise, a Cleveland-based non-profit organization.

The report said the Midwest experienced a 25 percent increase in 2006 for health care-related investments. ......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 01/24/07


Page: 1 2 3

Related biology technology :

1. Midwest life science stocks kept sizzling in Q2
2. Midwest life science stocks sizzle in a tepid first quarter
3. A Midwest passage to India, Part II
4. Midwest offers non-stop flight to North Carolina research park
5. A Midwest life-science odyssey comes full circle
6. A Midwest small-cap, life-science surprise package
7. 2006: A mixed blessing for Midwest life science companies
8. Midwest gaining stature in nanotech research
9. Midwest colleges strong contenders for NIH funds
10. Japan on the rebound: Implications for Midwest
11. Investor links East Coast funds to Midwest tech
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Midwest hotter for healthcare investments

(Date:7/27/2015)... , ... July 27, 2015 , ... Production of high ... the past few years in the EU. For instance, it surpassed the EUR 106 ... 92 million mark in 2010. Germany is a major producer, while Italy is a ...
(Date:7/27/2015)... , ... July 27, 2015 , ... ... international sales network Monday. The venture will bring the world’s most efficient gas ... provides state-of-the-art equipment and technologies to both the industrial and municipal markets. With ...
(Date:7/27/2015)... 2015 IDEXX Laboratories, Inc. (NASDAQ: IDXX ... submitted over 100,000 specimens to IDEXX Reference Laboratories for ... 10 days since the breakthrough kidney function test launched ... leading cause of suffering and death in cats and ... with generally accepted kidney disease prevalence data showing that ...
(Date:7/24/2015)... July 24, 2015 Ryan & Maniskas, LLP ... United States District Court for the Northern District of ... entities that purchased the common stock of Avalanche Biotechnologies, Inc. ... 31, 2014 and June 15, 2015, inclusive (the "Class Period"). ... 2015, move the Court for appointment as a lead plaintiff ...
Breaking Biology Technology:High Tenacity Filament Yarn of Viscose Rayon Consumption to Grow Swiftly in the EU, Forecasts BAC Reports in New Study Available at MarketPublishers.com 2BlueInGreen Brings Water Treatment Technology to Florida 2Over 100,000 Pets Tested with New IDEXX SDMA Kidney Function Test Since Product Launch on July 13 2Over 100,000 Pets Tested with New IDEXX SDMA Kidney Function Test Since Product Launch on July 13 3Over 100,000 Pets Tested with New IDEXX SDMA Kidney Function Test Since Product Launch on July 13 4Over 100,000 Pets Tested with New IDEXX SDMA Kidney Function Test Since Product Launch on July 13 5Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Avalanche Biotechnologies, Inc. 2Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Avalanche Biotechnologies, Inc. 3
... BASINGSTOKE, England, March 25 Shire plc,(LSE: SHP, ... preliminary results prepared under International Financial,Reporting Standards ("IFRS") ... On February 21, 2008 Shire announced its ... Notes to Editors, Shire plc, Shire,s ...
... 25 Masimo (Nasdaq:,MASI), the inventor of ... pulse oximetry, today announced an agreement with,Switzerland-based ... of,electrocardiographs, spirometers, patient monitors and external,defibrillators, to ... as,the foundational technology of choice for all ...
... LANSING, Mich., March 25 Neogen Corporation,(Nasdaq: NEOG ... third quarter of,FY 2008, which ended Feb. 29, increased ... the quarter rose to $2,658,000, or $0.18 per share,compared ... net,income for the first nine months of Neogen,s 2008 ...
Cached Biology Technology:Shire plc: IFRS Results for the Year Ending December 31, 2007 2Shire plc: IFRS Results for the Year Ending December 31, 2007 3Shire plc: IFRS Results for the Year Ending December 31, 2007 4Shire plc: IFRS Results for the Year Ending December 31, 2007 5Shire plc: IFRS Results for the Year Ending December 31, 2007 6Shire plc: IFRS Results for the Year Ending December 31, 2007 7Shire plc: IFRS Results for the Year Ending December 31, 2007 8Shire plc: IFRS Results for the Year Ending December 31, 2007 9Shire plc: IFRS Results for the Year Ending December 31, 2007 10Shire plc: IFRS Results for the Year Ending December 31, 2007 11Shire plc: IFRS Results for the Year Ending December 31, 2007 12Shire plc: IFRS Results for the Year Ending December 31, 2007 13Shire plc: IFRS Results for the Year Ending December 31, 2007 14Shire plc: IFRS Results for the Year Ending December 31, 2007 15Shire plc: IFRS Results for the Year Ending December 31, 2007 16Shire plc: IFRS Results for the Year Ending December 31, 2007 17Shire plc: IFRS Results for the Year Ending December 31, 2007 18Shire plc: IFRS Results for the Year Ending December 31, 2007 19Shire plc: IFRS Results for the Year Ending December 31, 2007 20Shire plc: IFRS Results for the Year Ending December 31, 2007 21Shire plc: IFRS Results for the Year Ending December 31, 2007 22Shire plc: IFRS Results for the Year Ending December 31, 2007 23Shire plc: IFRS Results for the Year Ending December 31, 2007 24Shire plc: IFRS Results for the Year Ending December 31, 2007 25Shire plc: IFRS Results for the Year Ending December 31, 2007 26Shire plc: IFRS Results for the Year Ending December 31, 2007 27Shire plc: IFRS Results for the Year Ending December 31, 2007 28Shire plc: IFRS Results for the Year Ending December 31, 2007 29Shire plc: IFRS Results for the Year Ending December 31, 2007 30Shire plc: IFRS Results for the Year Ending December 31, 2007 31Shire plc: IFRS Results for the Year Ending December 31, 2007 32Shire plc: IFRS Results for the Year Ending December 31, 2007 33Schiller AG Adopts Masimo Rainbow SET as Their Technology Platform of Choice for Patient Monitoring Devices Worldwide 2Schiller AG Adopts Masimo Rainbow SET as Their Technology Platform of Choice for Patient Monitoring Devices Worldwide 3Schiller AG Adopts Masimo Rainbow SET as Their Technology Platform of Choice for Patient Monitoring Devices Worldwide 4
(Date:7/21/2015)... , July 21, 2015  NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile ... wallet, announces that it has filed provisional patent ... Method. This invention highlights next ... authorizes an account, but also the user using ...
(Date:7/9/2015)...  Synaptics Inc. (NASDAQ: SYNA ), a leading developer ... report financial results for the fourth quarter and fiscal ... close of market. The company will host a corresponding ... PT (5:00 p.m. ET), during which management may discuss ... live call, analysts and investors should dial 888-455-2260 (conference ...
(Date:7/8/2015)... FRANKLIN LAKES , N.J. and NEW YORK ... and Company) and Guidepoint today announced ... selected start-up healthcare companies with free access to Guidepoint,s ... mentoring several start-ups that are developing cutting-edge technologies to ... of a dedicated Guidepoint research manager, each start-up entrepreneur ...
Breaking Biology News(10 mins):NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3
... a robotic arm to grab objects in a new computer ... University of Central Florida researchers thought the ease of the ... But they were wrong many participants in a pilot ... Most participants preferred the manual mode, which requires them to ...
... Applied Cancer Science (Belfer Institute) and sanofi-aventis (EURONEXT: ... have entered into a collaboration and license option ... targets for further discovery and development by sanofi-aventis ... and related biomarkers. Research at the Belfer ...
... rhino with a ridiculously supersized head." "Fifteen long, pointed sideways ... one at the tip of each cheek bone, and ten across ... large horn over the nose and short, blunt eye horns that ... to describe two newly discovered species of dinosaurs with looks only ...
Cached Biology News:Robotic arm's big flaw: Patients say it's 'too easy' 2Dana-Farber and sanofi-aventis establish cancer research alliance 2New species of multi-horned dinosaurs unearthed in Utah 2
Sterile detoxified 10% bovine serum albumin (BSA) in Iscoves MDM. This BSA has been selected to support the optimal colony growth of human hematopoietic progenitor cells in methylcellulose-based medi...
... The TNT Coupled Reticulocyte Lysate Systems(a,b,c,d) ... in vitro translations: a single-tube, coupled ... greatly simplify the process and reduce ... vitro translation results. Standard rabbit reticulocyte ...
... ml per liter of urine will give a ... BMD dipstick. ,Certification: The Donors are of ... to be NEGATIVE for HbsAg, HCV, HIV-1 & ... FDA methods. THIS MATERIAL IS SOLD FOR IN-VITRO ...
... to the DH-2000, except that it uses a ... wavelength range and comes with a shutter (controlled ... 5 Hz) The DH-2000 Deuterium Tungsten ... deuterium and tungsten halogen light sources in a ...
Biology Products: